Its pretty much unprecedented, especially when youre talking about one in four adults being eligible for these drugs under the widest standards
But on GLP-1 medications, the standard advice of just eat more fiber ignores a fundamental problem
G.Moreno-VsquezM
Choosing Between Semaglutide and Tirzepatide for Microdosing From a pharmacology standpoint, semaglutide is a pure GLP-1 receptor agonist , while tirzepatide is a dual GIP/GLP-1 agonist that activates both GIP and GLP-1 receptors.[2,4] That dual mechanism likely contributes to tirzepatides strong weight-loss results at full doses compared with semaglutide in head-to-head and indirect comparisons.[2,7] In the context of microdosing: Some clinicians and patients feel that microdosing tirzepatide provides robust appetite control even at relatively low doses, though this is based largely on real-world experience rather than large trials
doi: 10.1038/s41575-022-00658-y 6 AdolphTEMeyerMJukicATilgH
GLP-1 COA GLP-1 injections as a 'central planning' intervention in cellular energy economics Cellular energy economics was proposed by Zhang Xingyuan in "Fermentation Principles", and its core lies in the dynamic balance of microbial cells achieving "maximum survival benefits with minimal metabolic consumption" through metabolic regulation
